CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 72.3% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jan 01, 22:43

Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales

Novavax Inc
Webhose 2025 Dec 30, 09:30

Novavax Covid-19 vaccine available at selected GP clinics in Singapore from Jan 2 to May 31

Novavax Inc
Webhose 2025 Dec 30, 01:43

Novavax COVID-19 vaccine available at some GP clinics until May 31

Novavax Inc
Webhose 2025 Dec 25, 03:45

Novavax (NVAX) Is Up 6.3% After Activist Sale Push and Sanofi-Focused Royalty Pivot - What's Changed - Simply Wall St News

Novavax Inc
Webhose 2025 Dec 21, 20:17

Novavax (NVAX): Weighing Undervaluation Claims Against Fading Momentum and DCF Signals

Novavax Inc
Webhose 2025 Dec 21, 04:10

Evaluating Novavax's Current Valuation After Steep Five Year Share Price Collapse

Novavax Inc
Webhose 2025 Dec 14, 07:19

Novavax (NVAX) Valuation Check as FDA Scrutiny Rises and Activist Pushes for Possible Sale

Novavax Inc
Webhose 2025 Dec 09, 06:15

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Brokerages

Novavax Inc

Novavax news

Latest news

Show more

Info

Spread

0.05

Spread (%)

0.7052 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1158617856

Shares Outstanding

162498995

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

2.01

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Trustpilot